[The effect of lidoflazine on the excitation process in the resting and stress ECG in coronary patients (author's transl)].
D000328:Adult; D000368:Aged; D000787:Angina Pectoris / Q000188:drug therapy; D001145:Arrhythmias, Cardiac / Q000139:chemically induced; D005117:Cardiac Complexes, Premature / Q000175:diagnosis; D003327:Coronary Disease / Q000188:drug therapy*; D003937:Diagnosis, Differential; D004562:Electrocardiography; D005080:Exercise Test; D005260:Female; D006329:Heart Conduction System / Q000187:drug effects*; D006801:Humans; D007008:Hypokalemia / Q000175:diagnosis; D008013:Lidoflazine / Q000009:adverse effects / Q000494:pharmacology* / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D010879:Piperazines / Q000494:pharmacology*
D010879:Piperazines; D008013:Lidoflazine
Die Wirkung von Lidoflazin auf den Erregungsablauf im Ruhe- und Belastungs-EKG beim Koronarkranken